Skip to main content
Top
Published in: Journal of Nuclear Cardiology 6/2014

Open Access 01-12-2014 | Original Article

The effect of beta blocker withdrawal on adenosine myocardial perfusion imaging

Authors: C. Hoffmeister, R. Preuss, MD, R. Weise, W. Burchert, MD, PhD, O. Lindner, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 6/2014

Login to get access

Abstract

Background

The effect of beta blockers on myocardial blood flow (MBF) under vasodilators has been studied in several SPECT and PET myocardial perfusion imaging (MPI) studies with divergent results. The present study evaluated the effect of a beta blocker withdrawal on quantitative adenosine MBF and on MPI results.

Methods

Twenty patients with beta blockers and CAD history were studied with quantitative adenosine N-13 ammonia PET. The first study was performed under complete medication and the second after beta blocker withdrawal. The PET studies were independently read with respect to MPI result and clinical decision making.

Results

Global MBF showed an increase from 180.2 ± 59.9 to 193.6 ± 60.8 mL·minute−1/100 g (P = .02) after beta blocker withdrawal. The segmental perfusion values were closely correlated (R 2 = 0.82) over the entire range of perfusion values. An essentially different interpretation after beta blocker discontinuation was found in two cases (10%).

Conclusion

A beta blocker withdrawal induces an increase in adenosine MBF. In the majority of cases, MPI interpretation and decision making are independent of beta blocker intake. If a temporary beta blocker withdrawal before MPI is not possible or was not realized by the patient, it is appropriate to perform adenosine stress testing without loss of the essential MPI result.
Literature
1.
go back to reference Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55.PubMedCrossRef Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55.PubMedCrossRef
2.
go back to reference Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.PubMedCrossRef Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.PubMedCrossRef
3.
go back to reference Lindner O, Bengel FM, Hacker M, Schafer W, Burchert W. Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012. Eur J Nucl Med Mol Imaging 2014;41:963-71.PubMedCentralPubMedCrossRef Lindner O, Bengel FM, Hacker M, Schafer W, Burchert W. Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012. Eur J Nucl Med Mol Imaging 2014;41:963-71.PubMedCentralPubMedCrossRef
4.
go back to reference Chan SY, Brunken RC, Czernin J, Porenta G, Kuhle W, Krlvokapich J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992;20:979-85.PubMedCrossRef Chan SY, Brunken RC, Czernin J, Porenta G, Kuhle W, Krlvokapich J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992;20:979-85.PubMedCrossRef
5.
go back to reference Goudarzi B, Fukushima K, Bravo P, Merrill J, Bengel FM. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: A quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET. Eur J Nucl Med Mol Imaging 2011;38:1908-16.PubMedCrossRef Goudarzi B, Fukushima K, Bravo P, Merrill J, Bengel FM. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: A quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET. Eur J Nucl Med Mol Imaging 2011;38:1908-16.PubMedCrossRef
6.
go back to reference Hoffman JI. Maximal coronary flow and the concept of coronary vascular reserve. Circulation 1984;70:153-9.PubMedCrossRef Hoffman JI. Maximal coronary flow and the concept of coronary vascular reserve. Circulation 1984;70:153-9.PubMedCrossRef
7.
go back to reference Zoghbi GJ, Iskandrian AE. Selective adenosine agonists and myocardial perfusion imaging. J Nucl Cardiol 2012;19:126-41.PubMedCrossRef Zoghbi GJ, Iskandrian AE. Selective adenosine agonists and myocardial perfusion imaging. J Nucl Cardiol 2012;19:126-41.PubMedCrossRef
8.
go back to reference Bridges AB, Kennedy N, McNeill GP, Cook B, Pringle TH. The effect of atenolol on dipyridamole 201Tl myocardial perfusion tomography in patients with coronary artery disease. Nucl Med Commun 1992;13:41-6.PubMedCrossRef Bridges AB, Kennedy N, McNeill GP, Cook B, Pringle TH. The effect of atenolol on dipyridamole 201Tl myocardial perfusion tomography in patients with coronary artery disease. Nucl Med Commun 1992;13:41-6.PubMedCrossRef
9.
go back to reference Sharir T, Rabinowitz B, Livschitz S, Moalem I, Baron J, Kaplinsky E, et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 1998;31:1540-6.PubMedCrossRef Sharir T, Rabinowitz B, Livschitz S, Moalem I, Baron J, Kaplinsky E, et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 1998;31:1540-6.PubMedCrossRef
10.
go back to reference Taillefer R, Ahlberg AW, Masood Y, White CM, Lamargese I, Mather JF, et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol 2003;42:1475-83.PubMedCrossRef Taillefer R, Ahlberg AW, Masood Y, White CM, Lamargese I, Mather JF, et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol 2003;42:1475-83.PubMedCrossRef
11.
go back to reference Bottcher M, Refsgaard J, Madsen MM, Randsbaek F, Kaltoft A, Nielsen HE, et al. Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia. J Nucl Cardiol 2003;10:345-52.PubMedCrossRef Bottcher M, Refsgaard J, Madsen MM, Randsbaek F, Kaltoft A, Nielsen HE, et al. Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia. J Nucl Cardiol 2003;10:345-52.PubMedCrossRef
12.
go back to reference Reyes E, Stirrup J, Roughton M, D’Souza S, Underwood SR, Anagnostopoulos C, et al. Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective beta-adrenoceptor blockers: A crossover myocardial perfusion imaging study. J Nucl Med 2010;51:1036-43.PubMedCrossRef Reyes E, Stirrup J, Roughton M, D’Souza S, Underwood SR, Anagnostopoulos C, et al. Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective beta-adrenoceptor blockers: A crossover myocardial perfusion imaging study. J Nucl Med 2010;51:1036-43.PubMedCrossRef
13.
go back to reference Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005;32:855-97.PubMedCrossRef Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005;32:855-97.PubMedCrossRef
14.
go back to reference Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med 2013;54:1485-507.PubMedCrossRef Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med 2013;54:1485-507.PubMedCrossRef
15.
go back to reference Yoon AJ, Melduni RM, Duncan SA, Ostfeld RJ, Travin MI. The effect of beta-blockers on the diagnostic accuracy of vasodilator pharmacologic SPECT myocardial perfusion imaging. J Nucl Cardiol 2009;16:358-67.PubMedCrossRef Yoon AJ, Melduni RM, Duncan SA, Ostfeld RJ, Travin MI. The effect of beta-blockers on the diagnostic accuracy of vasodilator pharmacologic SPECT myocardial perfusion imaging. J Nucl Cardiol 2009;16:358-67.PubMedCrossRef
17.
go back to reference Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-42.PubMedCrossRef Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-42.PubMedCrossRef
18.
go back to reference Blomqvist G. On the construction of functional maps in positron emission tomography. J Cereb Blood Flow Metab 1984;4:629-32.PubMedCrossRef Blomqvist G. On the construction of functional maps in positron emission tomography. J Cereb Blood Flow Metab 1984;4:629-32.PubMedCrossRef
19.
go back to reference van den Hoff J, Burchert W, Borner AR, Fricke H, Kühnel G, Meyer GJ, et al. [1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med 2001;42:1174-82.PubMed van den Hoff J, Burchert W, Borner AR, Fricke H, Kühnel G, Meyer GJ, et al. [1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med 2001;42:1174-82.PubMed
20.
go back to reference Kotzerke J, Glatting G, van den Hoff J, Höher M, Neumaier B, Wöhrle J, et al. Validation of myocardial blood flow estimation with nitrogen-13 ammonia PET by the argon inert gas technique in humans. Eur J Nucl Med 2001;28:340-5.PubMedCrossRef Kotzerke J, Glatting G, van den Hoff J, Höher M, Neumaier B, Wöhrle J, et al. Validation of myocardial blood flow estimation with nitrogen-13 ammonia PET by the argon inert gas technique in humans. Eur J Nucl Med 2001;28:340-5.PubMedCrossRef
21.
go back to reference Hachamovitch R, Berman DS. The use of nuclear cardiology in clinical decision making. Semin Nucl Med 2005;35:62-72.PubMedCrossRef Hachamovitch R, Berman DS. The use of nuclear cardiology in clinical decision making. Semin Nucl Med 2005;35:62-72.PubMedCrossRef
22.
23.
go back to reference Silke B. Beta-blockade in CHF: Pathophysiological considerations. Eur Heart J Suppl 2006;8:C13-8.CrossRef Silke B. Beta-blockade in CHF: Pathophysiological considerations. Eur Heart J Suppl 2006;8:C13-8.CrossRef
24.
go back to reference Muller-Suur R, Eriksson SV, Strandberg LE, Mesko L. Comparison of adenosine and exercise stress test for quantitative perfusion imaging in patients on beta-blocker therapy. Cardiology 2001;95:112-8.PubMedCrossRef Muller-Suur R, Eriksson SV, Strandberg LE, Mesko L. Comparison of adenosine and exercise stress test for quantitative perfusion imaging in patients on beta-blocker therapy. Cardiology 2001;95:112-8.PubMedCrossRef
25.
go back to reference Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974;34:48-55.PubMedCrossRef Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974;34:48-55.PubMedCrossRef
26.
go back to reference Bottcher M, Czernin J, Sun K, Phelps ME, Schelbert HR. Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med 1997;38:442-6.PubMed Bottcher M, Czernin J, Sun K, Phelps ME, Schelbert HR. Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med 1997;38:442-6.PubMed
27.
go back to reference Koepfli P, Wyss CA, Namdar M, Klainguti M, von Schulthess GK, Lüscher TF, et al. Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: Differential effects in stenotic versus remote myocardial segments. J Nucl Med 2004;45:1626-31.PubMed Koepfli P, Wyss CA, Namdar M, Klainguti M, von Schulthess GK, Lüscher TF, et al. Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: Differential effects in stenotic versus remote myocardial segments. J Nucl Med 2004;45:1626-31.PubMed
28.
go back to reference Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008;88:1009-86.PubMedCrossRef Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008;88:1009-86.PubMedCrossRef
29.
go back to reference Becker LC. Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia. Circulation 1978;57:1103-10.PubMedCrossRef Becker LC. Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia. Circulation 1978;57:1103-10.PubMedCrossRef
Metadata
Title
The effect of beta blocker withdrawal on adenosine myocardial perfusion imaging
Authors
C. Hoffmeister
R. Preuss, MD
R. Weise
W. Burchert, MD, PhD
O. Lindner, MD, PhD
Publication date
01-12-2014
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 6/2014
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-014-9952-y

Other articles of this Issue 6/2014

Journal of Nuclear Cardiology 6/2014 Go to the issue

Nuclear Cardiology in the Literature

A selection of recent, original research papers